| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000017914 |
| Receipt No. | R000019949 |
| Official scientific title of the study | Comparison of PD and bile duct resection for middle bile duct cancer (Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?) Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery Biliary part |
| Date of disclosure of the study information | 2015/07/01 |
| Last modified on | 2017/12/18 (Ver. 4) |
| Basic information | |||
| Official scientific title of the study | Comparison of PD and bile duct resection for middle bile duct cancer
(Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?) Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery Biliary part |
||
| Title of the study (Brief title) | Comparison of PD and bile duct resection for middle bile duct cancer
(Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?) Japan-Korea Collaborative Research |
||
| Region |
|
||
| Condition | ||
| Condition | Middle bile duct cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the surgical outcomes of bile duct segmental resection (BDSR) and Pancreaticoduodenectomy (PD) for middle bile duct cancer
To verify whether the additional PD after BDSR to achieve negative bile duct margin have similar survival as straightforward PD. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | desease free survival |
| Key secondary outcomes | Overall survival
R0 resection rate Morbidity rate Mortality rate Recurrence rate Site of Recurrence |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Middle bile duct cancer (definition of middle bile duct cancer is described above)
-Resected between 2001-2010 -Clinically T1, T2, T3 (without invasion to liver parenchyma by preoperative diagnostic imaging and intraoperative macroscopic findings) in TNM 7th classification (ICD-O C24.0) (cT1/2/3 but pT4 cancer should be included) -M0 -Surgical strategies are defined as bile duct segmental resection (BDSR), pancreaticoduodenectomy including PD, PpPD and SSPPD (PD) and additional PD (AdPD). |
|||
| Key exclusion criteria | -Bismuth type I hilar cholangiocarcinoma
-cT4 cancer (With invasion to liver parenchyma by preoperative diagnostic imaging and intraoperative macroscopic findings) (cT1/2/3 but pT4 cancer should not be excluded) -M1 desease -Preoperative chemotherapy and/or radiation -With hepatectomy (additional hepatectomy after BDSR or PD is excluded in this study) -Patient with other cancer within 5-year |
|||
| Target sample size | 3600 | |||
| Research contact person | |
| Name of lead principal investigator | Michiaki Unno |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan |
| TEL | 022-717-7205 |
| m_unno@surg1.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Hiroki Hayashi |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan |
| TEL | 022-717-7205 |
| Homepage URL | |
| hiroki@surg1.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Japanese Ssociety of Hepato-Biliary-Pancreatic Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Biliary part of Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery
Biliary part |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019949 |